Ecotrin Related Published Studies
Well-designed clinical trials related to Ecotrin (Aspirin)
A combination of esomeprazole and aspirin reduces tissue concentrations of
prostaglandin E(2) in patients with Barrett's esophagus. [2012]
Aspirin for the prevention of cognitive decline in the elderly: rationale and
design of a neuro-vascular imaging study (ENVIS-ion). [2012]
Evaluation of onset of pain relief from micronized aspirin in a dental pain
model. [2012]
Aspirin for primary prevention of vascular events in women: individualized prediction of treatment effects. [2011.12]
Impact of preoperative maintenance or interruption of aspirin on thrombotic and bleeding events after elective non-cardiac surgery: the multicentre, randomized, blinded, placebo-controlled, STRATAGEM trial. [2011.12]
Impact of a Fixed-Dose Combination of Naproxen and Esomeprazole Magnesium on Serum Thromboxane B(2) Inhibition by Low-Dose Aspirin Over 5 Days in Healthy Adults: A Phase I, Randomized, Double-Blind, Placebo-Controlled, Noninferiority Trial. [2011.11.09]
Effect of aspirin dose on mortality and cardiovascular events in people with diabetes: a meta-analysis. [2011.11]
A randomized clinical trial comparing point-of-care platelet function assays and bleeding time in healthy subjects treated with aspirin or clopidogrel. [2011.09.15]
Aspirin use and breast cancer risk: a meta-analysis. [2011.09.04]
Platelet response to aspirin 50 and 100 mg in patients with coronary heart disease over a five-year period. [2011.09.01]
Tirofiban use with clopidogrel and aspirin decreases adverse cardiovascular events after percutaneous coronary intervention for ST-elevation myocardial infarction: a meta-analysis of randomized trials. [2011.09]
Batroxobin plus aspirin reduces restenosis after angioplasty for arterial occlusive disease in diabetic patients with lower-limb ischemia. [2011.07]
Efficacy of Lactobacillus casei treatment on small bowel injury in chronic low-dose aspirin users: a pilot randomized controlled study. [2011.07]
Randomized clinical trial of aspirin and simvastatin for pulmonary arterial hypertension: ASA-STAT. [2011.06.28]
Terutroban versus aspirin in patients with cerebral ischaemic events (PERFORM): a randomised, double-blind, parallel-group trial. [2011.06.11]
Differential effect of low-dose aspirin for primary prevention of atherosclerotic events in diabetes management: a subanalysis of the JPAD trial. [2011.06]
Cost effectiveness of warfarin versus aspirin in patients older than 75 years with atrial fibrillation. [2011.06]
Lansoprazole for secondary prevention of gastric or duodenal ulcers associated with long-term low-dose aspirin therapy: results of a prospective, multicenter, double-blind, randomized, double-dummy, active-controlled trial. [2011.06]
A randomized placebo-controlled prevention trial of aspirin and/or resistant starch in young people with familial adenomatous polyposis. [2011.05]
Use of aspirin associates with longer primary patency of hemodialysis grafts. [2011.04]
The efficacy of host response modulation therapy (omega-3 plus low-dose aspirin) as an adjunctive treatment of chronic periodontitis (clinical and biochemical study). [2011.04]
Aspirin, warfarin, or enoxaparin thromboprophylaxis in patients with multiple myeloma treated with thalidomide: a phase III, open-label, randomized trial. [2011.03.10]
Economic evaluation of clopidogrel plus aspirin for secondary prevention of cardiovascular events in Canada for patients with established cardiovascular disease: Results from the CHARISMA trial. [2011.03]
Clopidogrel versus dipyridamole in addition to aspirin in reducing embolization detected with ambulatory transcranial Doppler: a randomized trial. [2011.03]
Variability and persistence of aspirin response in lower extremity peripheral arterial disease patients. [2011.03]
Rationale and design of a phase II clinical trial of aspirin and simvastatin for the treatment of pulmonary arterial hypertension: ASA-STAT. [2011.03]
Low-dose aspirin therapy in patients with type 2 diabetes and reduced glomerular filtration rate: subanalysis from the JPAD trial. [2011.02]
Clopidogrel plus aspirin versus aspirin alone for preventing cardiovascular disease. [2011.01.19]
Evaluation of small bowel blood flow in healthy subjects receiving low-dose aspirin. [2011.01.14]
A randomized pilot trial for aggressive therapeutic approaches in aspirin-resistant patients undergoing percutaneous coronary intervention. [2011.01]
Randomized comparison of platelet function monitoring to adjust antiplatelet therapy versus standard of care: rationale and design of the assessment with a double randomization of (1) a fixed dose versus a monitoring-guided dose of aspirin and clopidogrel after DES implantation, and (2) treatment interruption versus continuation, 1 year after stenting (ARCTIC) study. [2011.01]
Effects of zinc-L-carnosine and vitamin E on aspirin-induced gastroduodenal injury in dogs. [2011.01]
Comparison of the effect of cilostazol with aspirin on circulating endothelial progenitor cells and small-dense LDL cholesterol in diabetic patients with cerebral ischemia: a randomized controlled pilot trial. [2011]
The Japanese aggrenox (extended-release dipyridamole plus aspirin) stroke prevention versus aspirin programme (JASAP) study: a randomized, double-blind, controlled trial. [2011]
The effect of aspirin on C-reactive protein in hypertensive patients. [2011]
The utility of Aspirin in Dukes C and High Risk Dukes B Colorectal cancer--the
ASCOLT study: study protocol for a randomized controlled trial. [2011]
Short-term acetylsalicylic acid (aspirin) use for pain, fever, or colds -
gastrointestinal adverse effects: a meta-analysis of randomized clinical trials. [2011]
Impact of adjunctive cilostazol therapy on platelet function profiles in patients
with and without diabetes mellitus on aspirin and clopidogrel therapy. [2011]
Batroxobin plus aspirin reduces restenosis after angioplasty for arterial
occlusive disease in diabetic patients with lower-limb ischemia. [2011]
Clopidogrel versus dipyridamole in addition to aspirin in reducing embolization
detected with ambulatory transcranial Doppler: a randomized trial. [2011]
Effects of zinc-L-carnosine and vitamin E on aspirin-induced gastroduodenal
injury in dogs. [2011]
Aspirin plus clopidogrel versus aspirin alone after coronary artery bypass grafting: the clopidogrel after surgery for coronary artery disease (CASCADE) Trial. [2010.12.21]
Randomized trial of aspirin and clopidogrel versus aspirin alone for the prevention of coronary artery bypass graft occlusion: the Preoperative Aspirin and Postoperative Antiplatelets in Coronary Artery Bypass Grafting study. [2010.12]
Results of the Cilostazol Stroke Prevention Study II (CSPS II), a randomized controlled trial for the comparison of cilostazol and aspirin in stroke patients. [2010.11]
Aspirin is beneficial in hypertensive patients with chronic kidney disease: a post-hoc subgroup analysis of a randomized controlled trial. [2010.09.14]
Rationale and design of a randomized, double-blind trial comparing the effects of a 3-month clopidogrel-aspirin regimen versus aspirin alone for the treatment of high-risk patients with acute nondisabling cerebrovascular event. [2010.09]
Efficacy and safety of angiotensin receptor blockade are not modified by aspirin in patients with chronic heart failure: a cohort study from the Candesartan in Heart failure--Assessment of Reduction in Mortality and morbidity (CHARM) programme. [2010.07]
Role of aspirin in tuberculous meningitis: a randomized open label placebo controlled trial. [2010.06.15]
Effect of aspirin, other NSAIDs, and statins on PSA and PSA velocity. [2010.06.01]
Dose-related effect of aspirin on laboratory-defined platelet aggregation and clinical outcome after coronary stenting. [2010.06]
Effect of maximum OTC doses of naproxen sodium or acetaminophen on low-dose aspirin inhibition of serum thromboxane B2. [2010.06]
Platelet hyperfunction is decreased by additional aspirin loading in patients presenting with myocardial infarction on daily aspirin therapy. [2010.06]
Aspirin resistance is associated with glycemic control, the dose of aspirin, and obesity in type 2 diabetes mellitus. [2010.06]
Hyperglycemia-induced platelet activation in type 2 diabetes is resistant to aspirin but not to a nitric oxide-donating agent. [2010.06]
SPIN (Scottish Pregnancy Intervention) study: a multicenter, randomized controlled trial of low-molecular-weight heparin and low-dose aspirin in women with recurrent miscarriage. [2010.05.27]
Safety of fixed-dose aspirin-extended-release dipyridamole in patients with ischemic heart disease. [2010.05.01]
Adjuvant aspirin therapy reduces symptoms of schizophrenia spectrum disorders: results from a randomized, double-blind, placebo-controlled trial. [2010.05]
[Investigation of the effects of low dose aspirin therapy on primary and secondary prevention of cardiovascular disease] [2010.05]
Hypothesis formulation from subgroup analyses: nonadherence or nonsteroidal anti-inflammatory drug use explains the lack of clinical benefit of aspirin on first myocardial infarction attributed to "aspirin resistance". [2010.05]
Clopidogrel plus aspirin versus aspirin alone for reducing embolisation in patients with acute symptomatic cerebral or carotid artery stenosis (CLAIR study): a randomised, open-label, blinded-endpoint trial. [2010.05]
Aspirin plus heparin or aspirin alone in women with recurrent miscarriage. [2010.04.29]
Warfarin and aspirin use in atrial fibrillation among practicing cardiologist (from the AFFECTS Registry). [2010.04.15]
Low-dose aspirin in the primary prevention of rheumatoid arthritis: the Women's Health Study. [2010.04]
Effect of combined aspirin and extended-release dipyridamole versus clopidogrel on functional outcome and recurrence in acute, mild ischemic stroke: PRoFESS subgroup analysis. [2010.04]
Aspirin for prevention of cardiovascular events in a general population screened for a low ankle brachial index: a randomized controlled trial. [2010.03.03]
Effect of two doses of aspirin on thromboxane biosynthesis and platelet function in patients undergoing coronary surgery. [2010.03.01]
Aspirin-triggered lipoxin in patients treated with aspirin and selective vs. nonselective COX-2 inhibitors. [2010.03]
Rationale, design, and baseline data of the Japanese Primary Prevention Project (JPPP)-a randomized, open-label, controlled trial of aspirin versus no aspirin in patients with multiple risk factors for vascular events. [2010.03]
To continue or discontinue aspirin in the perioperative period: a randomized, controlled clinical trial. [2010.03]
Randomized, double-blind, pilot study of geranylgeranylacetone versus placebo in patients taking low-dose enteric-coated aspirin. Low-dose aspirin-induced small bowel damage. [2010.03]
Effect of intravenous tirofiban and aspirin in reducing short-term and long-term neurologic deficit in patients with ischemic stroke: a double-blind randomized trial. [2010.02]
Early treatment with aspirin plus extended-release dipyridamole for transient ischaemic attack or ischaemic stroke within 24 h of symptom onset (EARLY trial): a randomised, open-label, blinded-endpoint trial. [2010.02]
Treatment of aspirin-resistant patients with omega-3 fatty acids versus aspirin dose escalation. [2010.01.12]
Continuation of low-dose aspirin therapy in peptic ulcer bleeding: a randomized trial. [2010.01.05]
Sex differences in the administration-time-dependent effects of low-dose aspirin on ambulatory blood pressure in hypertensive subjects. [2010.01]
Effects of aspirin and NO-aspirin (NCX 4016) on platelet function and coagulation in human endotoxemia. [2010]
Aspirin plus clopidogrel versus aspirin alone after coronary artery bypass
grafting: the clopidogrel after surgery for coronary artery disease (CASCADE)
Trial. [2010]
Lafutidine prevents low-dose aspirin and loxoprofen induced gastric injury: a
randomized, double-blinded, placebo controlled study. [2010]
Baseline plasma total homocysteine and adenoma recurrence: results from a double
blind randomized clinical trial of aspirin and folate supplementation. [2010]
Rationale and design of a randomized, double-blind trial comparing the effects of
a 3-month clopidogrel-aspirin regimen versus aspirin alone for the treatment of
high-risk patients with acute nondisabling cerebrovascular event. [2010]
Adjunctive treatment of chronic periodontitis with daily dietary supplementation
with omega-3 Fatty acids and low-dose aspirin. [2010]
Dose-related effect of aspirin on laboratory-defined platelet aggregation and
clinical outcome after coronary stenting. [2010]
Hypothesis formulation from subgroup analyses: nonadherence or nonsteroidal
anti-inflammatory drug use explains the lack of clinical benefit of aspirin on
first myocardial infarction attributed to "aspirin resistance". [2010]
Role of aspirin in tuberculous meningitis: a randomized open label placebo
controlled trial. [2010]
Aspirin with or without an antiemetic for acute migraine headaches in adults. [2010]
Low-dose aspirin in the primary prevention of rheumatoid arthritis: the Women's
Health Study. [2010]
Aspirin for prevention of cardiovascular events in a general population screened
for a low ankle brachial index: a randomized controlled trial. [2010]
Effect of intravenous tirofiban and aspirin in reducing short-term and long-term
neurologic deficit in patients with ischemic stroke: a double-blind randomized
trial. [2010]
Low-Dose Aspirin and Medical Record-Confirmed Age-Related Macular Degeneration in a Randomized Trial of Women. [2009.10.06]
Time-Dependent Effects of Low-Dose Aspirin on Plasma Renin Activity, Aldosterone, Cortisol, and Catecholamines. [2009.10.05]
Randomized controlled trial of aspirin and clopidogrel versus aspirin and placebo on markers of smooth muscle proliferation before and after peripheral angioplasty. [2009.10]
Platelet inhibitory effects of OTC doses of naproxen sodium compared with prescription dose naproxen sodium and low-dose aspirin. [2009.10]
Lower incidence of hypertensive complications during pregnancy in patients treated with low-dose aspirin during in vitro fertilization and early pregnancy. [2009.10]
Preliminary trial of rebamipide for prevention of low-dose aspirin-induced gastric injury in healthy subjects: a randomized, double-blind, placebo-controlled, cross-over study. [2009.09]
Aspirin Use and the Risk of Gastric Cancer: A Meta-Analysis. [2009.08.12]
Sarpogrelate versus aspirin in secondary prevention of cerebral infarction: differential efficacy in diabetes? Subgroup analysis from S-ACCESS. [2009.08]
Ambulatory blood pressure control with bedtime aspirin administration in subjects with prehypertension. [2009.08]
[Effects of probucol, aspirin and atorvastatin combination therapy upon atherosclerosis] [2009.07.28]
Famotidine for the prevention of peptic ulcers and oesophagitis in patients taking low-dose aspirin (FAMOUS): a phase III, randomised, double-blind, placebo-controlled trial. [2009.07.11]
Clopidogrel and aspirin versus clopidogrel alone on graft patency after coronary artery bypass grafting. [2009.07]
Effect of aspirin on hypothalamic-pituitary-adrenal function and on neuropsychological performance in healthy adults: a pilot study. [2009.07]
|
